Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
May 02, 2025 at 01:19 AM EDT
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.
